Summary of mass spectrometry, CTL, and tetramer analysis
| Patient . | Peptide in eluate . | CTL generated . | Tetramer staining . |
|---|---|---|---|
| 1 | Positive | Positive | Positive |
| 2 | Positive | Positive | Positive |
| 3 | Positive | Positive | Positive (after ex vivo expansion) |
| 5 | — | Positive | Negative (ex vivo expansion not attempted) |
| 6 | Negative | — | Negative |
| 9 | N/A | — | Negative |
| Patient . | Peptide in eluate . | CTL generated . | Tetramer staining . |
|---|---|---|---|
| 1 | Positive | Positive | Positive |
| 2 | Positive | Positive | Positive |
| 3 | Positive | Positive | Positive (after ex vivo expansion) |
| 5 | — | Positive | Negative (ex vivo expansion not attempted) |
| 6 | Negative | — | Negative |
| 9 | N/A | — | Negative |
Cases not studied by HLA-A3/KQSSKALQR tetramer are excluded. CTL, cytotoxic T lymphocytes; N/A, not applicable; —, not done.